Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1871 1
1952 2
1953 2
1956 1
1957 1
1958 1
1960 1
1961 5
1962 1
1963 6
1965 3
1966 1
1967 4
1968 5
1969 3
1970 9
1971 8
1972 3
1973 7
1974 3
1975 9
1976 3
1977 6
1978 5
1979 11
1980 9
1981 7
1982 9
1983 16
1984 12
1985 19
1986 14
1987 16
1988 16
1989 19
1990 18
1991 20
1992 12
1993 17
1994 17
1995 16
1996 13
1997 14
1998 12
1999 10
2000 13
2001 22
2002 16
2003 13
2004 14
2005 17
2006 21
2007 13
2008 18
2009 19
2010 20
2011 18
2012 41
2013 33
2014 25
2015 30
2016 27
2017 28
2018 33
2019 27
2020 38
2021 37
2022 50
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

925 results

Results by year

Filters applied: . Clear all
Page 1
Targeting multidrug resistance in cancer.
Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Szakács G, et al. Among authors: ludwig ja. Nat Rev Drug Discov. 2006 Mar;5(3):219-34. doi: 10.1038/nrd1984. Nat Rev Drug Discov. 2006. PMID: 16518375 Review.
Ewing's Sarcoma.
Ludwig JA, Meyers PA, Dirksen U. Ludwig JA, et al. N Engl J Med. 2021 Apr 15;384(15):1476. doi: 10.1056/NEJMc2102423. N Engl J Med. 2021. PMID: 33852792 No abstract available.
Oncolytic virus immunotherapy: future prospects for oncology.
Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS. Raja J, et al. Among authors: ludwig jm. J Immunother Cancer. 2018 Dec 4;6(1):140. doi: 10.1186/s40425-018-0458-z. J Immunother Cancer. 2018. PMID: 30514385 Free PMC article. Review.
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W. Hilf N, et al. Among authors: ludwig j. Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Nature. 2019. PMID: 30568303 Clinical Trial.
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Löffler MW, Gori S, Izzo F, Mayer-Mokler A, Ascierto PA, Königsrainer A, Ma YT, Sangro B, Francque S, Vonghia L, Inno A, Avallone A, Ludwig J, Alcoba DD, Flohr C, Aslan K, Mendrzyk R, Schuster H, Borrelli M, Valmori D, Chaumette T, Heidenreich R, Gouttefangeas C, Forlani G, Tagliamonte M, Fusco C, Penta R, Iñarrairaegui M, Gnad-Vogt U, Reinhardt C, Weinschenk T, Accolla RS, Singh-Jasuja H, Rammensee HG, Buonaguro L. Löffler MW, et al. Among authors: ludwig j. Clin Cancer Res. 2022 Jun 13;28(12):2555-2566. doi: 10.1158/1078-0432.CCR-21-4424. Clin Cancer Res. 2022. PMID: 35421231 Clinical Trial.
Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA.
Vlatkovic I, Ludwig J, Boros G, Szabó GT, Reichert J, Buff M, Baiersdörfer M, Reinholz J, Mahiny AJ, Şahin U, Karikó K. Vlatkovic I, et al. Among authors: ludwig j. Pharmaceutics. 2022 Jan 29;14(2):328. doi: 10.3390/pharmaceutics14020328. Pharmaceutics. 2022. PMID: 35214060 Free PMC article.
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma.
Lamhamedi-Cherradi SE, Maitituoheti M, Menegaz BA, Krishnan S, Vetter AM, Camacho P, Wu CC, Beird HC, Porter RW, Ingram DR, Ramamoorthy V, Mohiuddin S, McCall D, Truong DD, Cuglievan B, Futreal PA, Velasco AR, Anvar NE, Utama B, Titus M, Lazar AJ, Wang WL, Rodriguez-Aguayo C, Ratan R, Livingston JA, Rai K, MacLeod AR, Daw NC, Hayes-Jordan A, Ludwig JA. Lamhamedi-Cherradi SE, et al. Among authors: ludwig ja. Nat Commun. 2022 Jun 1;13(1):3057. doi: 10.1038/s41467-022-30710-z. Nat Commun. 2022. PMID: 35650195 Free PMC article.
925 results